"We will maintain an open dialogue with our stakeholders and report annually on our performance." |
||
We define our stakeholders very broadly as all groups in society having a stake or interest in Novo Nordisk's environmental and bioethical performance. As the deterioration of the global environment continues and the limits for what we thought science and technology could achieve are transgressed, the number of stakeholder groups has increased progressively since the end of the 1980s. More and more people in society now feel they have a stake in what industrial companies are doing to improve their environmental and ethical performance. Stakeholder consultation is a very important part of our proactive strategy because the interaction helps us understand and identify new and evolving issues on the global agenda for sustainable development. Examples of ongoing activities with stakeholder groups include meetings with authorities, visits to our plants for local communities and NGO visits. WWF & Novo Nordisk Biodiversity Grant Fund |
||
![]() |
||
At the WWF/Novo Nordisk Biodiversity Award ceremony at Amalienborg Castle in March 1998 are from the left: Tommy Dybbro, WWF, HRH Prince Henrik of Denmark, President of the Danish branch of WWF, Bent Muus, Chairman of the Scientific Committee of WWF, and Søren Ring Ibsen, who received DKK 25,000 for a project to evaluate the natural value of a Danish forest. In the background are Lise Kingo, Hanne Gürtler and Mads Øvlisen from Novo Nordisk. |
||
Environmental visits Environmental reporting Conference on Agenda 21 |
||
![]() |
||
Environmental compliance worldwide |
||||